The Revised European-American Classification of Lymphoid Neoplasms (REAL): A preferred approach for the classification of cutaneous lymphomas

被引:27
作者
Sander, CA
Flaig, MJ
Kaudewitz, P
Jaffe, ES
机构
[1] NCI, Hematopathol Sect, Pathol Lab, Bethesda, MD 20892 USA
[2] Univ Munich, Dept Dermatol, D-8000 Munich, Germany
关键词
cutaneous lymphoma; T cell; B cell; non-Hodgkin lymphoma;
D O I
10.1097/00000372-199906000-00012
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The Revised European-American Classification of Lymphoid Neoplasms (REAL) classification is based on the principle that each type of lymphoma is a distinct disease defined by morphology, immunophenotypic and genetic features, clinical presentation, and course. If either primary or secondary involvement of the skin is a constant factor, this aspect is considered integral to disease definition. Organ-specific classification schemes, such as that proposed by the European Organization for Research and Treatment of Cancer (EORTC) for cutaneous lymphomas, are not required, and indeed may impede the recognition of common features of diseases involving multiple anatomic sites. The use of multiple classification systems is a step backward, and may lead to confusion among hematologists/oncologists and dermatologists. Nevertheless, cutaneous lymphomas in many instances are distinct. Their natural history is often more indolent than nodal lymphomas, and for that reason they often require different therapeutic approaches. We agree with the efforts of the EORTC classification to emphasize the unique clinical aspects of many cutaneous lymphomas, as this recognition is essential for appropriate clinical management. As has been learned for nodal lymphomas, clinical features play an important role in prognosis and should be used in guiding therapy. For cutaneous lymphomas, the presence or absence of systemic spread is particularly important.
引用
收藏
页码:274 / 278
页数:5
相关论文
共 25 条
[1]   Marginal zone lymphoma (low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type) of skin and subcutaneous tissue - A study of 15 patients [J].
Bailey, EM ;
Ferry, JA ;
Harris, NL ;
Mihm, MC ;
Jacobson, JO ;
Duncan, LM .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1996, 20 (08) :1011-1023
[2]   A SUBCUTANEOUS DELTA-POSITIVE T-CELL LYMPHOMA THAT PRODUCES INTERFERON-GAMMA [J].
BURG, G ;
DUMMER, R ;
WILHELM, M ;
NESTLE, F ;
OTT, MM ;
FELLER, A ;
HEFNER, H ;
LANZ, U ;
SCHWINN, A ;
WIEDE, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (15) :1078-1081
[3]   BCL-2 PROTEIN EXPRESSION AND CORRELATION WITH THE INTERCHROMOSOMAL-1418 TRANSLOCATION IN CUTANEOUS LYMPHOMAS AND PSEUDOLYMPHOMAS [J].
CERRONI, L ;
VOLKENANDT, M ;
RIEGER, E ;
SOYER, HP ;
KERL, H .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1994, 102 (02) :231-235
[4]   CUTANEOUS FOLLICULAR LYMPHOMA [J].
GARCIA, CF ;
WEISS, LM ;
WARNKE, RA ;
WOOD, GS .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1986, 10 (07) :454-463
[5]   T-CELL LYMPHOMA INVOLVING SUBCUTANEOUS TISSUE - A CLINICOPATHOLOGICAL ENTITY COMMONLY ASSOCIATED WITH HEMOPHAGOCYTIC SYNDROME [J].
GONZALEZ, CL ;
MEDEIROS, LJ ;
BRAZIEL, RM ;
JAFFE, ES .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1991, 15 (01) :17-27
[6]  
HARRIS NL, 1994, BLOOD, V84, P1361
[7]   MALIGNANT-LYMPHOMA OF MUCOSA-ASSOCIATED LYMPHOID-TISSUE [J].
ISAACSON, PG ;
SPENCER, J .
HISTOPATHOLOGY, 1987, 11 (05) :445-462
[8]  
ISAACSON PG, 1994, EXTRANODAL LYMPHOMAS, P2
[9]  
Jaffe ES, 1999, AM J CLIN PATHOL, V111, pS8
[10]  
KAUDEWITZ P, 1990, CURR PROBL DERMATOL, V19, P150